Reuters logo
2 years ago
BRIEF-Oxford Pharmascience to start pilot clinical study for Oxpzero Ibuprofen
August 12, 2015 / 6:18 AM / 2 years ago

BRIEF-Oxford Pharmascience to start pilot clinical study for Oxpzero Ibuprofen

Aug 12 (Reuters) - Oxford Pharmascience Group Plc

* Preliminary pharmacokinetic data and initiation of pilot clinical study to demonstrate improved GI profile for oxpzero ibuprofen

* Company has commenced dosing in second phase of study

* Headline results on second phase are expected to be released in q4 2015, along with complete pk data and further taste masking assessments Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below